A strategic partnership between Xenetic Biosciences and Scripps Research was expanded on August 13, 2025, to advance proof-of-concept studies.
5 reports, 1 independent
Updated Aug 7
Gone quiet
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A strategic partnership between Xenetic Biosciences and Scripps Research was expanded on August 13, 2025, to advance proof-of-concept studies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Partnership expanded to advance proof-of-concept studies.1 source
The partnership between Xenetic and Scripps advanced its DNase platform development.1 source
Keep exploring
The entities involved
-
Xenetic Biosciences (United Kingdom)
company in London, United Kingdom
Nothing else this week.
-
Scripps Research
nonprofit American medical research facility that focuses on research and education in the biomedical sciences
Nothing else this week.
Coverage
Newest first; wire copies grouped- ACCESS NewswireXenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results Expanded strategic partnership with The Scripps Research Institute to advance proof-of-concept studies and further develop its
- ACCESS NewswireXenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform Research and development collaboration program to include additi